24 January | 11:00 - 12:00 CET
Technology is transforming healthcare and pharma innovation is stronger than ever. In Europe, the scope for bringing technology and innovation to patients is defined by both the pharma industry and policymakers. Each have an important role to play in creating an environment that supports medical breakthroughs.
Join us as we discuss the challenges of enhancing the pharma innovation ecosystem in Europe, considering what’s needed to attract life science investors to the region in the face of fierce global competition.
How can the European Commission’s new pharmaceutical strategy support the region’s research ecosystem What could be the short and long-term consequences of changes in European pharma regulation? What can be done to support sustainable access to the next generation of treatments in Europe? These are some of the questions that our guest speakers will address during the panel discussion.
Our expert panel